Ferris Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Ferris Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-440	Closed	-$36K	–	384
2019 Q1	$36K	Hold	440	–	–	0.01%	297
2018 Q4	$24K	Hold	440	–	–	0.01%	317
2018 Q3	$23K	Hold	440	–	–	0.01%	353
2018 Q2	$18K	Hold	440	–	–	0.01%	378
2018 Q1	$19K	Buy	+440	New	+$22.4K	0.01%	406
2017 Q3	–	Sell	-440	Closed	-$22K	–	358
2017 Q2	$22K	Buy	+440	New	+$20.5K	0.01%	349

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ferris Capital's IONS Position: Q2 2019 in Review

Ferris Capital sold out of Ionis Pharmaceuticals (IONS) in Q2 2019, closing a stake of 440 shares — an estimated $36K sold.

Ferris Capital first reported a position in IONS in Q2 2017 and held it in 6 quarters. The position peaked at $36K in Q1 2019. 396 funds tracked by Wall St. Rank hold IONS as of Q2 2019.

Ferris Capital reported no remaining Ionis Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Ferris Capital sold 440 Ionis Pharmaceuticals shares in Q2 2019, an estimated $36K.
Ferris Capital first reported a position in Ionis Pharmaceuticals in Q2 2017 and held it in 6 quarters.
Ferris Capital's Ionis Pharmaceuticals position peaked at $36K in Q1 2019.
396 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2019.

Based on Ferris Capital's 13F filing for Q2 2019, filed 18 Jul 2019.